tm logo
TAKEDA ONCOLOGY 1POINT
Dead/Abandoned
ABANDONED - EXPRESS

express

on 07 Jan 2020

Last Applicant/ Owned by

1-1, Doshomachi 4-chome, Chuo-ku,

Osaka

540-8645

Serial Number

87445723 filed on 11th May 2017

Registration Number

N/A

Correspondent Address

Karl M. Zielaznicki, Esq.

Troutman Sanders LLP

c/o IP Services NYC

875 Third Avenue

New York NY 10022

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"ONCOLOGY"

TAKEDA ONCOLOGY 1POINT

"ONCOLOGY" Providing medical and scientific research information in the field of haematological malignancies, cancer, auto-immune and inflammatory diseases and disorders TAKEDA ONCOLOGY ONE POINT Financial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information BusinRead More

Classification Information


Class [035]
Advertising, Business & Retail Services


Business administration of patient reimbursement program; business administration of medication reimbursement programs and services


First Use Date in General

27th Aug 2018

First Use Date in Commerce

27th Aug 2018

Class [036]
Insurance & Financial Services


Financial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information


First Use Date in General

27th Aug 2018

First Use Date in Commerce

27th Aug 2018

Class [042]
Computer & Software Services & Scientific Services


Providing medical and scientific research information in the field of haematological malignancies, cancer, auto-immune and inflammatory diseases and disorders


First Use Date in General

27th Aug 2018

First Use Date in Commerce

27th Aug 2018

Class [044]
Medical, Beauty & Agricultural Services


Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders


First Use Date in General

27th Aug 2018

First Use Date in Commerce

27th Aug 2018

Mark Details


Serial Number

No 87445723

Mark Type

No Service Mark

Attorney Docket Number

No 255541000010

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th Jan 2020ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
07th Jan 2020ABANDONMENT - EXPRESS MAILED
06th Jan 2020TEAS EXPRESS ABANDONMENT RECEIVED
29th Aug 2019NOTIFICATION OF FINAL REFUSAL EMAILED
29th Aug 2019SU - FINAL REFUSAL - WRITTEN
29th Aug 2019FINAL REFUSAL E-MAILED
15th Aug 2019TEAS/EMAIL CORRESPONDENCE ENTERED
14th Aug 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
14th Aug 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
02th Aug 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED